fda glp-1 compounding crackdown news october 2025 National Hispanic Medical Association | The federal government is stepping up to stop counterfeit weight-loss drugs. In 2025, bipartisan lawmakers urged stronger enforcement Why the FDA is cracking

*This is the st andard monthly cost for anyone that has done a GLP-1 consult and has done their first month in our program

doi:10.1186/s12970-020-00377-2 Zhao JV, Burgess S, Fan B, Schooling CM

Weight loss is another effect of GLP-1 medications

Before combining medications, discuss optimizing your current therapy by ensuring adequate dosing and treatment duration, exploring FDA-approved alternatives like tirzepatide or phentermine-topiramate ER, intensifying lifestyle interventions with behavioral therapy, or considering metabolic surgery if you meet clinical criteria

Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial